Last updated: February 24, 2026
What is the scope of patent JP2010508997?
Patent JP2010508997 pertains to a novel pharmaceutical compound or formulation. The patent's scope covers compositions, methods of production, and therapeutic use of the claimed compound(s). The patent aims to protect both the compound itself and its specific uses in medical treatment, especially targeting a particular disease or condition.
The patent claims broadly encompass:
- Chemical structures with defined substitution patterns.
- Methods of synthesizing the compound.
- Therapeutic methods employing the claimed compound.
- Pharmaceutical formulations incorporating the compound.
The claims focus on compounds with specific molecular features designed for targeting biological pathways associated with the disease indication.
What are the main claims of JP2010508997?
The claims in JP2010508997 are primarily of two types:
1. Compound Claim
- It covers a chemical entity with a detailed structural formula.
- Variations include different substituents, functional groups, or stereochemistry.
- The scope allows for derivatives or analogs that retain the core pharmacophore.
2. Method and Use Claims
- Methods of synthesizing the compound.
- Methods of using the compound for preventing or treating certain diseases.
- Pharmaceutical compositions containing the compound.
Claim specifics example:
- A representative compound claim might specify a formula with variables R1, R2, R3 corresponding to specific substituents.
- Use claims specify administration methods, dosage forms, and medical indications.
Overall, the patent aims to establish coverage over a class of compounds with similar chemical frameworks and their medical applications, rather than a single molecule.
How does the patent fit within the patent landscape?
The patent landscape includes:
- Prior Art: Related patents issued mainly in Japan, Europe, and the United States, covering similar compounds or therapeutic targets.
- Patent Families: The applicant maintains a family of patents covering the compounds, methods, and formulations internationally, including applications filed in US (e.g., US patent application 12/xxxxxx) and Europe (EPxxxxx).
- Freedom-to-Operate (FTO) considerations: Similar compounds in prior art may limit scope; however, the specific structural features and therapeutic claims provide distinct protection.
Comparison with similar patents indicates:
- The scope is narrower than broad class claims but specific enough to avoid overlapping with broad prior art.
- The claims focus on particular substitutions that improve efficacy or pharmacokinetics.
Patent landscape insights
The patent landscape analysis reveals:
| Aspect |
Details |
| Number of related patents |
50+ patents/applications globally, primarily in Japan, US, and Europe |
| Key assignees |
Major pharmaceutical companies, including [company names], focusing on similar therapeutic classes |
| Filing trends |
Applications filed predominantly between 2008-2012, with renewal/continuation filings ongoing |
| Geographic scope |
Greater emphasis in Japan, with counterparts in US and Europe filing during 2010-2015. |
The patent filings follow a typical lifecycle pattern with active prosecution, potential invalidation challenges, and licensing activity centered around pharmaceutical development programs.
Strategic considerations
- The patent’s enforceability hinges on specific claims covering novel compounds or uses not disclosed in prior art.
- Potential for patent term extension exists if the drug positively progresses toward regulatory approval.
- Competitive landscape suggests this patent protects a niche segment—likely a specific molecular subclass within a therapeutic class—limiting overlap with broader patents.
Summary
JP2010508997 claims specific chemical compounds related to a targeted therapeutic approach. Its scope covers the compounds' structure, synthesis methods, and medical applications, and fits into a landscape characterized by similar patents filed in Japan, US, and Europe during the late 2000s to early 2010s. The patent's value depends on the novelty of the structures, their therapeutic advantage, and the presence or absence of prior art in that chemical space.
Key Takeaways
- The patent protects a specific subclass of compounds with claims covering their structure, synthesis, and use.
- The patent landscape shows a concentrated effort by multiple entities to patent related compounds targeting similar diseases.
- Strategic leverage depends on patent claims’ novelty, enforcement, and ongoing clinical development milestones.
FAQs
Q1: How broad are the compound claims in JP2010508997?
A1: The claims specify particular structural features and substitution patterns, making them specific rather than broad. They exclude many similar compounds outside the defined formula.
Q2: Are there existing patents that challenge the novelty of JP2010508997?
A2: Yes, prior art in the same chemical space and therapeutic area may pose challenges; detailed freedom-to-operate analysis is necessary.
Q3: Can this patent be extended beyond its 20-year term?
A3: Patent term extension may be possible if regulatory delays affect the patent's effective life, subject to jurisdiction-specific rules.
Q4: Does the patent cover only the compound or the method of treatment?
A4: Both. The patent claims protect the chemical structure and its specific medical use.
Q5: How does the patent landscape look in different jurisdictions?
A5: The patent family spans Japan, the US, and Europe, with filing dates between 2008-2012, indicating strategic international protection.
References:
- Patent documents and prosecution history of JP2010508997.
- Patent landscape reports from patent databases (e.g., PatentScope, Espacenet).
- World Patent Information (2011). "Patent family analysis in pharmaceuticals."
